Calithera Biosciences Inc. buy elfe
Start price
08.01.15
/
50%
€407.00
Target price
02.02.15
€640.00
Performance (%)
-14.87%
End price
02.02.15
€346.48
Summary
This prediction ended on 02.02.15 with a price of €346.48. The prediction for Calithera Biosciences Inc. disappointed with a performance of -14.87%. elfe has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Calithera Biosciences Inc. | - | - | - | - |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% | 53.697% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% | 76.697% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% | 60.793% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% | 62.807% |
Comments by elfe for this prediction
In the thread Calithera Biosciences diskutieren
Die Gesellschaft ist auf die Entwicklung niedermolektularer Wirkstoffe gegen Tumorstoffwechsel und Tumorimmologie.
Marktplazierung: 329,21 Millionen Euro
Anzahl der Aktien 17,93 Millionen
Kaufsignal.
http://www.finanzen.net/aktien/Calithera_Biosciences-Aktie
http://tickerreport.com/banking-finance/378743/zacks-analysts-give-average-recommendation-of-buy-to-calithera-biosciences-nasdaqcala/
(Vom Mitglied beendet)